SCHEMBL9923992

SCHEMBL9923992

Cc1ccc2nc(NS(=O)(=O)c3ccccc3)c(C)n2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.46
HPGD P15428 4/20 0.46
KDM4E B2RXH2 4/20 0.46
MAPT P10636 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HCRTR1 O43613 1/20 0.46
TSHR P16473 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
HSD17B10 Q99714 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
METAP2 P50579 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923911 0.87 KDM4E (0.47) HTR6HPGDKDM4EMAPTALDH1A1
SCHEMBL9893287 0.84 HSD11B1 (0.45) HPGDKDM4EMAPTALDH1A1TSHR
SCHEMBL9923872 0.83 MAPT (0.47) HTR6HPGDKDM4EMAPTALDH1A1
SCHEMBL9925340 0.72 ALDH1A1 (0.41) HPGDKDM4EMAPTALDH1A1HSD17B10
SCHEMBL9893199 0.70 ALDH1A1 (0.43) KDM4EMAPTALDH1A1TSHRHSD17B10
SCHEMBL9924043 0.70 KMT2A (0.48) KDM4EMAPTALDH1A1TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL9893200 0.69 KMT2A (0.47) KDM4EMAPTALDH1A1TSHRSMN1; SMN2
SCHEMBL9893198 0.69 ALDH1A1 (0.48) HPGDKDM4EMAPTALDH1A1TSHR
SCHEMBL9893206 0.69 MEN1 (0.46) KDM4EALDH1A1SMN1; SMN2NPSR1RXFP1
SCHEMBL18136532 0.67 NR1H4 (0.59) HPGDKDM4EMAPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 HTR6 407/4885HPGD 2697/4885KDM4E 3480/4885
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 HTR6 407/4885HPGD 2697/4885KDM4E 3480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.